Skip to content

Comparison of the Jcerity Endoscoper Airway with the LMA Supreme for Airway Management in Patients Undergoing Cerebral Aneurysm Embolization

Comparison of the Jcerity Endoscoper Airway with the LMA Supreme for Airway Management in Patients Undergoing Cerebral Aneurysm Embolization

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044133
Enrollment
Unknown
Registered
2021-03-11
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Aneurysm

Interventions

Group 1:Jcerity Endoscoper Airway
Group 2:LMA Supreme Airway

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 years and <= 65 years; 2) General anesthesia in patients undergoing cerebral aneurysm embolization; 3) ASA grade I or II; 4) 18kg/m2 <= BMI <= 28kg/m2; 5) Before the trial, the nature, significance, possible benefits, possible inconvenience and potential danger of the trial should be understood in detail, and the research procedure should be understood and the informed consent should be signed voluntarily.

Exclusion criteria

Exclusion criteria: 1) Neck deformity, high risk of lung aspiration of gastric contents, known or expected difficult airway, obesity (body mass index [BMI] > 30kg / m2), estimated operation time > 3 hours, decreased lung compliance, incisor defect and mouth opening limitation; 2) Those who could not obtain informed consent, or the researchers thought it was not suitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
one-time implantation rate;Blood staining degree of the mask;Peak airway pressure;

Secondary

MeasureTime frame
Quality of ventilation;sore throat;Postoperative oral bleeding;

Countries

China

Contacts

Public ContactYunqi Lv

The First Affiliated Hospital of Zhengzhou University

lyq260703@163.com+86 13939019005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026